IGNYTA, INC. – Trademark Portfolio

Entity Type: 03

IGNYTA, INC. has 30 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 44 (Medical Services). This trademark owner is based in SAN DIEGO, CA.

11111 Flintkote Avenue

SAN DIEGO, CA 92121

30 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (30 results)

Trademark Classifications

IGNYTA, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (9 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does IGNYTA, INC. have?

IGNYTA, INC. has 30 U.S. trademarks filed with the USPTO.

What trademark classes does IGNYTA, INC. file in?

IGNYTA, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is IGNYTA, INC.'s trademark registration success rate?

IGNYTA, INC. has a 0% trademark registration rate, with 0 out of 30 resolved applications resulting in successful registration. Currently, 0 applications are pending review.